| NANOVIRICIDES NEW DL-,01 |
| USA |
| Gesundheit |
| US6300873022 / A2PSNF |
| NV3P (Frankfurt) |
| FRA:NV3P, ETR:NV3P, NV3P:GR |
| - |
| https://www.nanoviricides.. |
|
Nanoviricides Inc. is a pioneering biotechnology company that focuses on the development of therapeutics to combat viral infections using nanotechnology. The company is dedicated to creating antiviral nanomedicine known as "nanoviricides," which are ..
>Volltext.. |
| 16.24 Mio. EUR |
| 11.9 Mio. EUR |
| - |
| -6.72 Mio. EUR |
| -7.19 Mio. EUR |
| -0.42 EUR |
| - |
| 4.45 Mio. EUR |
| -6.34 Mio. EUR |
| 4.31 |
| - |
| 21.71% |
| - |
| - |
| - |
| - |
| NANOVIRICIDES |
| 01.04.26 |
|